Patent · US Expired

2,5-Inter-o-phenylene-3,4-dinor-5,9.alpha.-epoxy-9-deoxy-PGF.sub.1 compounds

US4312810A · kind A · utility

2Cited by
7References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 1979
Grant dateJan 26, 1982
Priority date
Expiry dateJul 31, 1999

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/5456
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to certain structural and pharmacological analogs of prostacyclin (PGI.sub.2) and 5,6-dehydroprostacyclin (PGI.sub.1) and 5,9.alpha.-epoxy-9-deoxy-PGF.sub.1, wherein between the position beta to the carboxy (C-2) and C-5 there is substituted an inter-o-phenylene for the ethylene chain. These novel 2,5-inter-o-phenylene-3,4-dinor-prostaglandin or prostacyclin-type compounds are useful for certain of the same pharmacological purposes as prostacyclin, particularly being smooth muscle stimulators, blood pressure depressors and platelet aggregation inhibitors. Also provided are novel intermediates therefor, namely corresponding interphenylene-containing PGF.sub.2.alpha. and 5-halo-PGI.sub.1 and 6-halo-5,9.alpha.-epoxy-9-deoxy-PGF.sub.1 compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.